Integra LifeSciences Holdings (IART)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.016% |
| Hold Price * : | $25.09 |
| History |
Portfolio Manager |
Activity ▲ |
Share change |
% change to portfolio |
| Q3 2024 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 37.17% |
42,000 |
0.13 |
| Q2 2024 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 13.00% |
13,000 |
0.07 |
| ≡ |
Meridian Contrarian Fund |
Buy |
148,000 |
0.82 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
9,419 |
0.01 |
| Q1 2024 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 8.87% |
767 |
0.00 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 35.14% |
26,000 |
0.15 |
| Q4 2023 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 4.23% |
3,000 |
0.02 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 15.85% |
1,184 |
0.00 |
| Q3 2023 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 2.90% |
2,000 |
0.01 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 26.02% |
2,627 |
0.00 |
| Q2 2023 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 53.33% |
24,000 |
0.16 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 0.60% |
61 |
0.00 |
| Q1 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 65.76% |
4,029 |
0.00 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 2.17% |
1,000 |
0.01 |
| Q4 2022 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
6,127 |
0.01 |
| Q3 2022 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 2.22% |
1,000 |
0.01 |
| Q2 2022 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 7.14% |
3,000 |
0.02 |
| Q1 2022 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 6.67% |
3,000 |
0.02 |
| Q4 2021 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 9.76% |
4,000 |
0.03 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
7,007 |
0.01 |
| Q3 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 68.58% |
15,292 |
0.02 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Reduce 10.87% |
5,000 |
0.04 |
| Q2 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 126.34% |
12,447 |
0.01 |
| Q1 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 24.83% |
3,254 |
0.00 |
| Q4 2020 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 6.98% |
3,000 |
0.03 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 37.27% |
7,786 |
0.01 |
| Q3 2020 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 19.44% |
7,000 |
0.06 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
20,892 |
0.02 |
| Q2 2020 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 13.53% |
4,290 |
0.04 |
| Q1 2020 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 51.00% |
10,710 |
0.10 |
| Q4 2019 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 133.33% |
12,000 |
0.11 |
| Q3 2019 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 12.50% |
1,000 |
0.01 |
| Q2 2019 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Buy |
8,000 |
0.07 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.